Help raise awareness and provide fundingfor the research of rare kidney cancers like HLRCC in children and young adults.
Andrew Leee was diagnosed at the age of 19 with a rare kidney cancer known as HLRCC, which currently has no known cure. After being diagnosed, Andrew turned a negative in a positive and established Driven to Cure, a 501(c)(3) nonprofit organization to help others.
Andrew created Driven to Cure to join two of his biggest passions, cars and cancer awareness, and to serve something far greater than hims self. According to the American Cancer Society, kidney cancer affects 31,000 Americans annually, killing 11,900 of them. Andrew was told at the time of his diagnosis that he might survive a year or more. Andrew then chose to fight this horrible disease and to help others in this process. Driven to Cure’s goal is to bring awareness and additional research funding to find a cure soon for rare kidney cancer diseases, including the development of the next generation of drugs to help others. Your generous donation will help to accomplish this goal and will make a difference in the lives of children, young adults, and their families affected by these diseases. Since the founding of Driven to Cure 2016, we have raised $400,000 for the research of rare kidney cancers like HLRCC.
Company Details
- Founded
- -
- Address
- 8601 Georgia Ave,
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://www.driventocure.org/
- HQ
- Silver Spring, Maryland
- Competitors
- Life Science Cares Philadelphia, Evolston Capital.
Driven To Cure Questions
Driven To Cure's website is https://www.driventocure.org/
Driven To Cure's LinkedIn profile is https://www.linkedin.com/company/driven-to-cure
Driven To Cure's industry is
Hospitals and Health Care
Driven To Cure's top competitors are
Life Science Cares Philadelphia,
Evolston Capital.
Driven To Cure's categories are Hospitals and Health Care
Driven To Cure's founding year is 2016
